To help out, we have a 20% patient discount code on our website (code is RP20)
Because it targets two pathways, clinical trials have shown it can lead to even more significant weight loss
After 72 weeks of treatment: Average weight loss reached 20.2% with tirzepatide versus 13.7% with semaglutide Patients lost 22.8 kg on tirzepatide compared with 15.0 kg on semaglutide Waist circumference was reduced by 18.4 cm versus 13.0 cm Notably, 31.6% of tirzepatide users achieved more than 25% body-weight reduction, nearly double the proportion seen with semaglutide
Clean ingredients, no fillers finally something that delivers on the GLP-1 support promises
Bordone strongly recommends GLP-1s for patients with psoriasis if these conditions apply: A BMI over 30 A BMI over 27 with obstructive sleep apnea High blood pressure Abnormal cholesterol High fasting glucose Insulin resistance Prediabetes Ive seen firsthand how these medications can positively impact patients who have both psoriasis and metabolic conditions like obesity or type 2 diabetes, says Kopelman, who coordinates with her patients primary care providers when she feels a GLP-1 may help
Every one of them is preventable
